MedTrace Logo

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

NCT00308867 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 349

Last updated 2008-04-11

No results posted yet for this study

Summary

The aim of this study is to investigate how the efficacy and tolerability of PD P 506 A-PDT relate to the commonly used cryosurgery in the treatment of mild to moderate AK lesions located on the head. To be able to quantify the effect the patient will be allocated to one of three treatments: PD P 506 A-PDT, cryosurgery or placebo-PDT.

Conditions

  • Actinic Keratosis

Interventions

PROCEDURE

Photodynamic Therapy

PROCEDURE

Cryosurgery

Sponsors & Collaborators

  • photonamic GmbH & Co. KG

    lead INDUSTRY

Principal Investigators

  • Rolf-Marcus Szeimies, Professor MD · Klinikum der Universität Regensburg, Kinik und Poliklinik für Dermatologie

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-06-30
Completion
2007-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308867 on ClinicalTrials.gov